Nasal Drug Delivery Technology Market

Nasal Drug Delivery Technology Market by Dosage Forms (Spray, Drops, Gel, and Powder), Container Types (Pressurized and Non-Pressurized), Therapeutic Applications (Nasal Congestion, Rhinitis, Asthma, and Others), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa)- Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

  • Report ID: HC-877
  • Author: Growth Market Reports
  • Rating: 4.8
  • Total Reviews: 2
  • No. Of Pages: 186
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global nasal drug delivery technology market size was valued at USD 49 billion in 2020 and is anticipated to expand at a CAGR of 6.4% during the forecast period, 2021-2028. The growth of the market is attributed to the rising preferences for alternative sources of administration with respect to nasal drugs.
 

Nasal Drug Delivery Technology Market Key Takeaways


Nasal drug delivery is a process in which the drugs are insufflated to the nose of the host. There are two main routes of administration which are followed here, either the systematic administration which affects the entire circulatory systems or the topical administration which affects the particular target of the body mainly the nasal system of the host. Nasal drugs can be used in different applications such as migraine drugs, nicotine replacement, hormone treatments, medications for seizure emergencies, and decongestants for allergy & cold treatments.

According to the World Health Organization or the WHO, along with the Research and Development Review board, in 2017, 60% of American adults and 54% across the globe have multiple chronic conditions regarding nasal diseases every year. In 2020, this figure has reached 80% in America and over 70% across the globe due to the coronavirus impact. The COVID-19 pandemic has fueled the growth of the global nasal drug delivery technology market. The coronavirus mainly spread from the nasal cavities of patients and doctors found that there was a direct correlation between the treatment of coronavirus to that of the nasal drug delivery system. This steered to hospitals, clinics, and healthcare laboratories to focus more on the development of nasal drug delivery technology for the prevention and treatment of diseases.

Market Trends, Drivers, Restraints, and Opportunities

  • Increase in spending and investing by the companies towards nasal drug delivery technology is the primary reason for the projection of boosting the market growth during the forecast period, 2021-2028.
  • Rapid growth of the biopharmaceutical companies and thereby that industry can become a major factor in the boosting of the global nasal drug delivery technology market during the forecast period.
  • High prices for the development of nasal drug delivery technology and high cost of services from the company’s perspective is anticipated to hinder the global market growth.
  • Nasal drugs when used in high dosages, especially with no medical inspection can lead to addiction which leads to complicated nasal disorders such as difficulty in breathing and asthma. This uncertainty can hamper the nasal drug delivery technology market growth.
  • R&D investment and technological advancement are expected to offer significant opportunities for the market players. Due to the COVID pandemic, the nasal drug delivery needed to increase their commercialization processes towards new & novel products, such as therapeutic sprays which helps in the diagnosis of blood sugar.

Scope of the Report

The report on the global nasal drug delivery technology market size includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Nasal Drug Delivery Technology Market Size - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Dosage Forms (Spray, Drops, Gel, and Powder), Container Types (Pressurized and Non-Pressurized), and Therapeutic Applications (Nasal Congestion, Rhinitis, Asthma, and Others)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Trends, and Revenue Forecast

Key Players Covered in the Report

GlaxoSmithKline plc; AstraZeneca plc; Pfizer Inc.; OptiNose Inc.; Becton, Dickinson and Company; Promius Pharma; LLC; Cadila Pharmaceuticals Ltd.; B.F Ascher and Company Inc.; PendoPharm Inc.; Douglas Pharmaceuticals Ltd.; ENT Technologies Pty Ltd.; and NAVEH Pharma Ltd.

 

Global Nasal Drug Delivery Technology Market Segment Insights

Spray segment is projected to represent a large market share
Based on dosage forms, the global nasal drug delivery technology market is divided into spray, drops, gel, and powder. The spray segment is expected to constitute the major share in 2019. The major reason attributing to this market growth is the due to the rising prevalence of allergic & infectious rhinitis and the increasing demand of multiple generic forms of nasal spray drugs.

Meanwhile the drop segment is anticipated to grow with a significant CAGR of 7.8% during the forecast period, 2021-2028, owing to the treatment success rates achieved by the nasal drops along with the affordability of this product, especially in developing economies.

Non-pressurized segment is estimated to register a huge market share
On the basis of container types, the global nasal drug delivery technology market is bifurcated into pressurized and non-pressurized. The non-pressurized segment is expected to constitute the major share of the market in 2019. This is attributed to the increasing demand for these related products along with the latest developments that has been focused upon this segment.

Meanwhile the pressurized segment is anticipated to grow with a significant CAGR of 7.6% during the forecast period, 2021-2028, owing to the rising incidences of nasal diseases, especially during the COVID pandemic for which pressurized containers are more advisable to use, even for various non-nasal diseases such as diabetes and cardiovascular diseases.

Asthma segment is anticipated to register a huge market share
Based on the therapeutic applications, the global nasal drug delivery technology market is segmented into nasal congestion, rhinitis, asthma, and others. The asthma segment is expected to constitute the major share of the market in 2019 and is estimated to grow with a significant CAGR of 6.9% during the forecast period, 2021-2028. The major reason attributing to this market growth is the rising incidences of asthma throughout the globe. The Globe Asthma Report stated that over 330 million people across the globe suffer from asthma and this figure found an exponential increase due to the coronavirus spread. Researchers and scientists have focused solely on the better treatment, diagnosis & cure for asthma along with the correlation between the coronavirus & its impact to asthma patients.   

 North America is anticipated to dominate the market
On the basis of regions, the global nasal drug delivery technology market is categorized as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. The market in North America is expected to constitute a major share in 2020. This regional market growth can be attributed to the growing research & development expenditure along with the rising in adoption of the latest technology. The demand of nasal drug delivery technology is increasing rapidly in this region due to the presence of the major market players in the nasal drug delivery technology market, an advantage other regions do not have. The cost of expenditure is significantly lower in North America than that of other economies. However, the market in Asia Pacific is anticipated to expand at a significant CAGR during the forecast period, 2021-2028, as they have prioritized the cost-efficiency perspective of Nasal Drug Delivery Technology combined with their growing population.
 

Nasal Drug Delivery Technology Market By Regions

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Nasal Drug Delivery Technology Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Nasal Drug Delivery Technology Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Nasal Drug Delivery Technology Market - Supply Chain
  4.5. Global Nasal Drug Delivery Technology Market Forecast
     4.5.1. Nasal Drug Delivery Technology Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Nasal Drug Delivery Technology Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Nasal Drug Delivery Technology Market Absolute $ Opportunity
5. Global Nasal Drug Delivery Technology Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Nasal Drug Delivery Technology Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Nasal Drug Delivery Technology Demand Share Forecast, 2019-2026
6. North America Nasal Drug Delivery Technology Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Nasal Drug Delivery Technology Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Nasal Drug Delivery Technology Demand Share Forecast, 2019-2026
7. Latin America Nasal Drug Delivery Technology Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Nasal Drug Delivery Technology Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Nasal Drug Delivery Technology Demand Share Forecast, 2019-2026
8. Europe Nasal Drug Delivery Technology Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Nasal Drug Delivery Technology Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Nasal Drug Delivery Technology Demand Share Forecast, 2019-2026
9. Asia Pacific Nasal Drug Delivery Technology Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Nasal Drug Delivery Technology Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Nasal Drug Delivery Technology Demand Share Forecast, 2019-2026
10. Middle East & Africa Nasal Drug Delivery Technology Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Nasal Drug Delivery Technology Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Nasal Drug Delivery Technology Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Nasal Drug Delivery Technology Market: Market Share Analysis
  11.2. Nasal Drug Delivery Technology Distributors and Customers
  11.3. Nasal Drug Delivery Technology Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. GlaxoSmithKline plc
     11.4.2. AstraZeneca plc
     11.4.3. Pfizer Inc.
     11.4.4. OptiNose Inc.
     11.4.5. Becton, Dickinson and Company

Segments Covered in the Report
The global nasal drug delivery technology market size has been segmented in terms of

Dosage Sprays

  • Spray
  • Drops
  • Gel
  • Powder

Container Types

  • Pressurized
  • Non-pressurized

Therapeutic Applications

  • Nasal Congestion
  • Rhinitis
  • Asthma
  • Others

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • GlaxoSmithKline plc
  • AstraZeneca plc
  • Pfizer Inc.
  • OptiNose Inc.
  • Becton, Dickinson and Company
  • Promius Pharma
  • LLC
  • Cadila Pharmaceuticals Ltd.
  • B.F Ascher and Company Inc.
  • PendoPharm Inc.
  • Douglas Pharmaceuticals Ltd.
  • ENT Technologies Pty Ltd.
  • NAVEH Pharma Ltd.

Major players competing in the global nasal drug delivery technology market are GlaxoSmithKline plc; AstraZeneca plc; Pfizer Inc.; OptiNose Inc.; Becton, Dickinson and Company; Promius Pharma; LLC; Cadila Pharmaceuticals Ltd.; B.F Ascher and Company Inc.; PendoPharm Inc.; Douglas Pharmaceuticals Ltd.; ENT Technologies Pty Ltd.; and NAVEH Pharma Ltd. These market players are involved in several business strategies such as mergers, acquisitions partnerships, collaborations, capacity expansion, and product launches to enhance their market shares. OptiNose Inc announced their pipeline project for the five year contract with the Research Council of Norway in 2016 and now renounced the deal to another five years. The primary thesis was to monitor and diagnose the nose-to-brain application, but in the renounced contract, OptiNose Inc wanted to include the coronavirus impact and its further implications along with the treatment program.

 

Nasal Drug Delivery Technology Market By Key Players

Buy Report